Severe Allergic And Eosinophilic Asthma clinical trials

Explore recruiting severe allergic and eosinophilic asthma clinical trials.

Also recruiting in Europe

Severe Allergic And Eosinophilic Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Predictive factors and magnitude of response to omalizumab and mepolizumab in allergic and eosinophilic severe asthma: PREDICTUMAB, an open-label, controlled, randomized multinational pragmatic trial.

Belgium, France

Therapeutic use (Phase IV) EU CTIS Study details

Severe Allergic And Eosinophilic Asthma trials by city

Severe Allergic And Eosinophilic Asthma in Toronto Severe Allergic And Eosinophilic Asthma in Vancouver Severe Allergic And Eosinophilic Asthma in Montreal Severe Allergic And Eosinophilic Asthma in Calgary Severe Allergic And Eosinophilic Asthma in Edmonton Severe Allergic And Eosinophilic Asthma in Ottawa Severe Allergic And Eosinophilic Asthma in Winnipeg Severe Allergic And Eosinophilic Asthma in Quebec City Severe Allergic And Eosinophilic Asthma in Hamilton Severe Allergic And Eosinophilic Asthma in Kitchener Severe Allergic And Eosinophilic Asthma in London Severe Allergic And Eosinophilic Asthma in Halifax Severe Allergic And Eosinophilic Asthma in New York Severe Allergic And Eosinophilic Asthma in Los Angeles Severe Allergic And Eosinophilic Asthma in Chicago Severe Allergic And Eosinophilic Asthma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease